india tirzepatide in Weight loss drug gets US nod to treat sleep apnea; India launch likely next year INDIA TO FINALLY APPROVE WEIGHT
Description
The therapeutic success of GLP-1 receptor agonists, which modulate both sweet taste perception and the hedonic valuation of food, underscores the potential of targeting this integrative system
An individualized plan based on medical history, current health status, and treatment goals helps maximize benefits while minimizing risks
Patients who stop treatment often regain weight, especially if lifestyle changes havent been fully integrated
AVNRT is not usually life-threatening, but treatment can improve symptoms like chest pain and dizziness
It is used with diet and lifestyle changes for diabetes and weight management
